DCOY is trading at 6.96% up now at $8.15 as its recent financing-driven rally continues, following a sharp move higher after a private placement announcement. The company secured approximately $3.5 million upfront and up to $21 million total through a PIPE deal with a healthcare-focused institutional investor, funding clinical trials for its antiviral programs, and traders are still reacting to this improved funding outlook.